Holen Sie sich die Stockscreener-App
19.53
0.29%
0.03
Schlusskurs vom Vortag:
$19.50
Offen:
$20.8
24-Stunden-Volumen:
12.13M
Relative Volume:
0.37
Marktkapitalisierung:
$4.45B
Einnahmen:
$2.35B
Nettoeinkommen (Verlust:
$128.37M
KGV:
37.41
EPS:
0.5221
Netto-Cashflow:
$57.42M
1W Leistung:
-1.43%
1M Leistung:
+24.25%
6M Leistung:
-66.38%
1J Leistung:
-25.07%
1-Tages-Spanne:
$19.51
$20.95
1-Wochen-Bereich:
$18.75
$20.95
52-Wochen-Spanne:
$13.74
$70.43
Hims Hers Health Inc Stock (HIMS) Company Profile
Firmenname
Hims Hers Health Inc
Sektor
Telefon
415-851-0195
Adresse
2269 CHESTNUT ST, SAN FRANCISCO
Compare HIMS vs TAK, ZTS, HLN, TEVA, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
19.52 | 4.44B | 2.35B | 128.37M | 57.42M | 0.5221 |
TAK
Takeda Pharmaceutical Co Adr
|
18.68 | 57.78B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
119.53 | 49.30B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
10.02 | 44.03B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.56 | 34.15B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
583.39 | 24.79B | 3.18B | 1.33B | 1.04B | 27.90 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-10 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2026-03-10 | Hochstufung | Citigroup | Sell → Neutral |
| 2026-03-09 | Hochstufung | Needham | Hold → Buy |
| 2026-02-24 | Herabstufung | BTIG Research | Buy → Neutral |
| 2026-01-12 | Eingeleitet | Evercore ISI | In-line |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-10-21 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2025-06-23 | Herabstufung | Needham | Buy → Hold |
| 2025-06-04 | Bestätigt | Needham | Buy |
| 2025-04-29 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-02-18 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-10 | Herabstufung | Citigroup | Neutral → Sell |
| 2025-01-07 | Eingeleitet | BTIG Research | Buy |
| 2024-12-17 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-11-14 | Herabstufung | BofA Securities | Buy → Underperform |
| 2024-08-22 | Eingeleitet | Needham | Buy |
| 2024-08-09 | Herabstufung | Imperial Capital | Outperform → In-line |
| 2024-05-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-04-16 | Herabstufung | Jefferies | Buy → Hold |
| 2024-04-10 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-02-28 | Hochstufung | Imperial Capital | In-line → Outperform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2023-12-07 | Eingeleitet | Imperial Capital | In-line |
| 2023-07-28 | Eingeleitet | TD Cowen | Outperform |
| 2023-04-11 | Eingeleitet | Robert W. Baird | Neutral |
| 2023-02-09 | Hochstufung | Jefferies | Hold → Buy |
| 2022-11-08 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-11-08 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-07-15 | Eingeleitet | SVB Leerink | Underperform |
| 2022-04-14 | Eingeleitet | Guggenheim | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-10 | Eingeleitet | Deutsche Bank | Hold |
| 2021-12-02 | Eingeleitet | Jefferies | Hold |
| 2021-11-11 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | Eingeleitet | BofA Securities | Neutral |
| 2021-05-20 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | Eingeleitet | Truist | Hold |
| 2021-03-09 | Eingeleitet | Credit Suisse | Neutral |
| 2021-03-02 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-02-17 | Eingeleitet | Citigroup | Neutral |
| 2021-02-12 | Eingeleitet | Piper Sandler | Neutral |
| 2021-02-08 | Eingeleitet | Tigress Financial | Buy |
Alle ansehen
Hims Hers Health Inc Aktie (HIMS) Neueste Nachrichten
Hims & Hers Health stock rises as FDA-approved Wegovy and Ozempic come back to market - tradersunion.com
HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with the Schall Law Firm - GlobeNewswire
Hims & Hers Health Is No Longer What The Market Thinks (NYSE:HIMS) - Seeking Alpha
BofA cuts Hims and Hers stock price target on EBITDA concerns - Investing.com
HIMS Stock Jumps Premarket: CEO Targets 100K Monthly Wegovy Push After Novo Nordisk Truce - Stocktwits
Okupe, Hims & Hers health CFO, sells $79k in shares - Investing.com India
Hims & Hers Health, Inc. (HIMS) Stock Dips While Market Gains: Key Facts - Yahoo Finance
Hims & Hers Faces Legal Scrutiny as Novo Nordisk Partnership Ends - timothysykes.com
Hims & Hers Faces Legal Scrutiny After Novo Nordisk Ends Partnership - timothysykes.com
Hackers access names, contact information of some Hims customers - Modern Healthcare
Hims & Hers Health (HIMS) Is Up 8.3% After Expanding Novo Nordisk GLP-1 Partnership And Launching New Weight-Loss MembershipHas The Bull Case Changed? - Yahoo Finance
3 Sectors to Buy While They’re Down and 1 to Walk Away From - Investing.com
Hims & Hers Health stock falls as insider files to sell shares - Investing.com
Why Is HIMS Stock Slipping Premarket Today? - Stocktwits
Hims & Hers Health and Fortune Brands Innovation have been highlighted as Zacks Bull and Bear of the Day - Zacks Investment Research
3 Sectors to Buy While They're Down and 1 to Walk Away From - MarketBeat
Hims & Hers Health, Inc. (82W.F) Stock Price, News, Quote & History - Yahoo! Finance Canada
Hims & Hers Health, Inc. (HIMS) stock price, news, quote and history - Yahoo Finance UK
Hims & Hers (HIMS) Taps Into $200-Billion Weight Loss Market, Soars 6% - insidermonkey.com
Hims & Hers Health, Inc. (HIMS) Stock Price, News, Quote & History - Yahoo! Finance Canada
NewsHims & Hers Health announces breach affecting patients' personal data - teiss
Hims & Hers says limited data stolen in social engineering attack - Healthcare Dive
Hims & Hers shares rise as investors refocus on growth outlook despite recent data-breach disclosure - Quiver Quantitative
Hims & Hers Advances a Consumer-Centric Digital Health Platform - The Globe and Mail
Hims & Hers Health (NYSE:HIMS) Shares Gap UpHere's Why - MarketBeat
Hims & Hers Skyrockets Post Novo Nordisk Collaboration Milestone - StocksToTrade
Hims & Hers Health stock climbs as price remains inside $18.90–$20.90 range - Traders Union
Hims & Hers Faces Investor Scrutiny Ahead of Quarterly Earnings - AD HOC NEWS
Hims & Hers Moves Forward with a Patient-Focused Online Healthcare Platform - Bitget
Best Healthcare Stocks To Add to Your WatchlistApril 5th - MarketBeat
2026-04-05 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Hims & Hers Health, Inc. (HIMS) And Encourages Shareholders to Reach Out | NYSE:HIMS | Press Release - Stockhouse
Hims & Hers Health, Inc. (NYSE:HIMS) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Hims & Hers Health Inc at Morgan Stanley Technology, Media & Telecom Conference Transcript - GuruFocus
Hims Data Breach Tests Trust As Valuation Gap Attracts Investors - Yahoo Finance
Hims & Hers Health Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Dir - PharmiWeb.com
Novo partnership fuels long-term optimism for Hims & Hers Health, Inc. (HIMS) - MSN
Data Breach Alert: Edelson Lechtzin LLP Investigates Hims & Hers, Inc. Data Breach - PR Newswire
Hims & Hers Health Faces Investor Lawsuit Over Alleged Misconduct - National Today
Hims & Hers Health Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Hims & Hers Health, Inc.HIMS - Business Wire
Hims & Hers hack: Telehealth company reports customer support system breach - The American Bazaar
Here's Why Hims & Hers Health, Inc. (HIMS) Fell More Than Broader Market - MSN
Barclays raises PT on Hims & Hers Health (HIMS) stock - MSN
HIMS Stock Gains As FDA Reportedly Moves Toward Lifting Restrictions On Peptides - Stocktwits
Healthcare Stocks To Watch TodayApril 3rd - MarketBeat
Hims & Hers warns of data breach after Zendesk support ticket breach - BleepingComputer
Hims and Hers reveal cyberattack — customer support system hacked and personal info stolen, here's what we know - TechRadar
Here is what to know beyond why Hims & Hers Health, Inc. (HIMS) is a trending stock - MSN
Hims & Hers' Valuations Back To EarthRobust Monetization Trends Deserve Reiterated Buy - Seeking Alpha
Hims & Hers Health stock price forecast: sideways consolidation likely as HIMS falls 3.53% - Traders Union
Here is What to Know Beyond Why Hims & Hers Health, Inc. (HIMS) is a Trending Stock - Yahoo Finance
HIMS stock gains as FDA reportedly moves toward lifting restrictions on peptides - MSN
Finanzdaten der Hims Hers Health Inc-Aktie (HIMS)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):